Pharmacognosy intro
Dragon's Blood from Croton lechleri contains taspine (PRIMARY alkaloid), an aporphine-benzylisoquinoline alkaloid that promotes fibroblast chemotaxis (migration toward wound), stimulates collagen production, and facilitates wound closure. Proanthocyanidins constitute >90% of dry weight, with SP-303 (crofelemer) as a specific proanthocyanidin oligomer providing antiviral and antidiarrheal properties. Additional compounds include flavan-3-ols (catechin, epicatechin, gallocatechin), lignans (dimethylcedrusine, 3',4-O-dimethylcedrusine) with wound-healing properties. The PRIMARY mechanism is taspine-driven fibroblast chemotaxis, it actively RECRUITS fibroblasts to the wound site, accelerating the proliferative phase of wound healing and explaining the traditional "liquid bandage" use. Dragon's blood also suppresses neurogenic inflammation by inhibiting substance P release from sensory neurons, providing BOTH anti-inflammatory and analgesic effects at the wound site. It blocks P2X4 purinergic receptors via PI3-kinase inhibition, a novel pain and inflammation mechanism. SP-303 blocks chloride ion secretion via CFTR and CaCC channels in intestinal epithelium, which is the mechanism behind FDA-approved crofelemer (Fulyzaq/Mytesi) for HIV-associated diarrhea, one of very few FDA-approved botanical drugs. ORAC antioxidant values are among the highest of any natural product.